BioAdaptives, Inc. (BDPT) income statement
BDPTOTCPharmaceutical PreparationsFiscal year ends December 31
$0.00−0.00 (-5.56%)
Close on Oct 19, 2026Market cap $478.03KP/E –Yield –
BioAdaptives, Inc. financial ratios
See a number that looks wrong?
Close on Oct 19, 2026Market cap $478.03KP/E –Yield –
See a number that looks wrong?
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2015 | FY2014 | FY2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Margins | ||||||||||||
| Gross margin | 68.4% | 31.8% | 37.9% | 41.5% | 51.1% | 37.3% | 49.2% | – | – | – | – | – |
| Operating margin | -5,701.8% | -4,752.5% | -801.4% | -2,456.3% | – | – | – | – | – | – | – | – |
| Pre-tax margin | -8,523.4% | -7,097.3% | – | – | – | -5,189.2% | -2,405.1% | – | – | – | – | – |
| Net profit margin | -8,523.4% | -7,097.3% | -2,494.2% | -5,214.1% | -5,309.2% | -5,189.2% | -2,405.1% | – | – | – | – | – |
| Free cash flow margin | -2,921.7% | -1,969.5% | – | – | – | – | – | – | – | – | – | – |
| Returns on capital | ||||||||||||
| Return on equity | 86.7% | 57.8% | 46.0% | 70.4% | 85.0% | 76.4% | 31.2% | 403.5% | – | 223.5% | -5,829.9% | – |
| Return on assets | -638.8% | -491.5% | -1,008.4% | -963.5% | -1,254.2% | -3,935.3% | -355.9% | -1,278.1% | – | -583.5% | -2,695.8% | – |
| Return on tangible assets | -677.7% | -491.5% | -1,290.3% | -995.5% | -1,254.2% | -3,935.3% | -355.9% | -1,278.1% | – | -583.5% | -2,695.8% | – |
| Return on capital employed | 58.0% | 38.7% | 14.8% | 33.2% | – | – | – | – | – | 223.4% | -5,515.2% | – |
| NOPAT | -$823.32K | -$475.65K | -$180.85K | -$333.30K | – | – | – | – | – | -$179.55K | -$1.92M | – |
| Cash flow quality | ||||||||||||
| OCF / Sales | -2,823.2% | -1,969.5% | -783.4% | -1,323.1% | -802.2% | -654.7% | -1,692.4% | – | – | – | – | – |
| OCF / Net income | 0.33 | 0.28 | 0.31 | 0.25 | 0.15 | 0.13 | 0.70 | 0.30 | – | 0.00 | 0.02 | – |
| FCF / OCF | 103.5% | 100.0% | – | – | – | – | – | – | – | – | 97.3% | – |
| FCF / Net income | 0.34 | 0.28 | – | – | – | – | – | – | – | – | 0.02 | – |
| Unlevered free cash flow | -$478.03K | -$176.85K | – | – | – | – | – | – | – | – | -$60.21K | – |
| Levered free cash flow | -$534.03K | -$249.52K | – | – | – | – | – | – | – | – | -$57.05K | – |
| Efficiency | ||||||||||||
| Asset turnover | 0.07 | 0.07 | 0.40 | 0.18 | 0.24 | 0.76 | 0.15 | – | – | – | – | – |
| Fixed asset turnover | 2.61 | – | – | – | – | – | – | – | – | – | – | – |
| Payables turnover | 0.03 | 0.03 | 0.04 | 0.05 | 0.22 | 0.17 | 0.12 | – | – | – | – | – |
| Days payables outstanding | 13,012.2 | 13,161.7 | 8,777.4 | 7,475.6 | 1,685.4 | 2,096.0 | 3,032.8 | – | – | – | – | – |
| Inventory turnover | 0.18 | 0.50 | 1.47 | 1.48 | 1.04 | 0.82 | 0.17 | – | – | – | – | – |
| Days inventory outstanding | 2,014.8 | 726.6 | 248.4 | 247.5 | 350.3 | 444.9 | 2,204.3 | – | – | – | – | – |
| CapEx to revenue | 98.5% | 0.00% | – | – | – | – | – | – | – | – | – | – |
| CapEx to OCF | -3.5% | -0.00% | – | – | – | – | – | – | – | – | -2.7% | – |
| Liquidity | ||||||||||||
| Current ratio | 0.09 | 0.15 | 0.05 | 0.02 | 0.07 | 0.01 | 0.03 | 0.15 | – | 0.03 | 0.98 | 3.78 |
| Quick ratio | 0.07 | 0.14 | 0.04 | 0.02 | 0.07 | 0.00 | 0.02 | 0.08 | – | 0.03 | 0.98 | 3.78 |
| Cash ratio | 0.07 | 0.08 | 0.03 | 0.02 | 0.07 | 0.00 | 0.02 | 0.08 | – | 0.02 | 0.96 | 3.73 |
| Working capital | -$2.14M | -$1.46M | -$1.66M | -$1.45M | -$1.15M | -$1.38M | -$839.88K | -$605.93K | – | -$203.90K | -$1.17K | $88.47K |
| Net current asset value | -$2.14M | -$1.46M | -$1.66M | -$1.45M | -$1.15M | -$1.38M | -$839.88K | -$693.74K | – | -$203.90K | -$1.17K | $88.47K |
| Leverage | ||||||||||||
| Assets to equity | -0.11 | -0.18 | -0.06 | -0.03 | -0.14 | -0.01 | -0.03 | -0.16 | – | -0.04 | -604.79 | 1.36 |
| Intangibles to total assets | 6.2% | 0.00% | 14.8% | 8.0% | – | 0.00% | – | – | – | – | – | – |
| Interest coverage | ||||||||||||
| EBIT / Interest expense | -14.70 | -6.55 | -1.41 | -1.46 | – | – | – | – | – | – | – | – |
| Per share | ||||||||||||
| Revenue per share | 0.0015 | 0.0015 | 0.0048 | 0.0001 | 0.0004 | 0.0008 | 0.0005 | – | – | – | – | – |
| EPS (basic) | – | -0.11 | -0.12 | – | – | -0.04 | -0.01 | -0.08 | – | -0.02 | -0.21 | – |
| EPS (diluted) | -0.15 | -0.11 | – | – | – | -0.04 | -0.01 | -0.08 | – | -0.02 | -0.21 | – |
| Book value per share | -0.18 | -0.18 | -0.28 | -0.0057 | -0.02 | -0.07 | -0.05 | -0.04 | – | -0.02 | -0.0000 | 0.0073 |
| Tangible book value per share | -0.18 | -0.18 | -0.28 | -0.0058 | -0.02 | -0.07 | -0.05 | -0.04 | – | -0.02 | -0.0000 | 0.0073 |
| Cash per share | 0.01 | 0.02 | 0.01 | 0.0001 | 0.0016 | 0.0002 | 0.0007 | 0.0033 | – | 0.0004 | 0.0054 | 0.0098 |
| Operating cash flow per share | -0.04 | -0.03 | -0.04 | -0.0009 | -0.0031 | -0.0051 | -0.0091 | -0.02 | – | -0.0000 | -0.0046 | – |
| Free cash flow per share | -0.04 | -0.03 | – | – | – | – | – | – | – | – | -0.0045 | – |
| CapEx per share | 0.0015 | 0.00 | – | – | – | – | – | – | – | – | 0.0001 | – |
| Valuation at period end | ||||||||||||
| Market cap | $241.75K | $73.90M | $58.24M | $4.57M | $53.70M | $70.51M | $391.32M | – | $414.78M | $248.36M | $852.96M | – |
| Enterprise value | $182.47K | $73.86M | $58.08M | $4.55M | $53.63M | $70.49M | $391.31M | – | $414.76M | $248.35M | $852.89M | – |
| P/S | 13.2x | 5,833x | 2,039x | 266x | 2,715x | 4,319x | 39,392x | – | – | – | – | – |
| P/B | -0.1x | -50.5x | -35.4x | -3.2x | -49.1x | -51.1x | -466x | – | -118,339x | -1,221x | -7,290,252x | – |
| P/TBV | -0.1x | -50.5x | -35.0x | -3.1x | -49.1x | -51.1x | -466x | – | -118,339x | -1,221x | -7,290,252x | – |
| P/Gross profit | 19.3x | 18,338x | 5,383x | 642x | 5,314x | 11,568x | 80,106x | – | – | – | – | – |
| P/OCF | -0.5x | -296x | -260x | -20.1x | -338x | -660x | -2,328x | – | – | -3,449,451x | -14,549x | – |
| EV/Sales | 10.0x | 5,830x | 2,033x | 265x | 2,712x | 4,318x | 39,391x | – | – | – | – | – |
| EV/Gross profit | 14.6x | 18,328x | 5,369x | 639x | 5,308x | 11,566x | 80,105x | – | – | – | – | – |
| EV/OCF | -0.4x | -296x | -260x | -20.0x | -338x | -660x | -2,328x | – | – | -3,449,373x | -14,547x | – |
| Earnings yield | -644.4% | -1.2% | -1.2% | -19.6% | -2.0% | -1.2% | -0.06% | – | – | -0.09% | -0.30% | – |
| FCF yield | -220.9% | -0.34% | – | – | – | – | – | – | – | – | -0.01% | – |
| Cost structure | ||||||||||||
| Stock-based comp to revenue | 156.9% | – | – | 0.00% | 828.8% | 288.6% | 0.00% | – | – | – | – | – |
| Per employee | ||||||||||||
| Total employees | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Revenue per employee | $18.28K | $12.67K | $28.57K | $17.18K | $19.78K | $16.33K | $9.93K | – | – | – | – | – |
| Gross profit per employee | $12.50K | $4.03K | $10.82K | $7.13K | $10.11K | $6.10K | $4.89K | – | – | – | – | – |
| Operating profit per employee | -$1.04M | -$602.09K | -$228.92K | – | – | – | – | – | – | -$227.28K | -$2.44M | – |
| Net income per employee | -$1.56M | -$899.16K | -$712.47K | -$895.57K | -$1.05M | -$847.24K | -$238.93K | -$1.41M | – | -$227.43K | -$2.58M | – |
| Free cash flow per employee | -$534.03K | -$249.52K | – | – | – | – | – | – | – | – | -$57.05K | – |
| Growth | ||||||||||||
| Revenue 1Y growth | 44.3% | -55.6% | 66.3% | -13.1% | 21.1% | 64.4% | – | – | – | – | – | – |
| Revenue 3Y CAGR | 2.1% | -13.8% | 20.5% | 20.0% | – | – | – | – | – | – | – | – |
| Revenue 5Y CAGR | 2.3% | 5.0% | – | – | – | – | – | – | – | – | – | – |
| Gross profit 1Y growth | 210.1% | -62.8% | 51.8% | -29.5% | 65.8% | 24.8% | – | – | – | – | – | – |
| Gross profit 3Y CAGR | 20.6% | -26.4% | 21.1% | 13.4% | – | – | – | – | – | – | – | – |
| Gross profit 5Y CAGR | 15.4% | -3.8% | – | – | – | – | – | – | – | – | – | – |
| EBIT 1Y growth | -73.1% | -163.0% | 45.7% | – | – | – | – | – | – | 90.7% | – | – |
| Net income 1Y growth | -73.3% | -26.2% | 20.4% | 14.7% | -23.9% | -254.6% | 83.0% | – | – | 91.2% | – | – |
| Diluted EPS 1Y growth | -36.4% | – | – | – | – | -300.0% | 87.5% | – | – | 90.5% | – | – |
| Operating cash flow 1Y growth | -106.8% | -11.5% | 1.5% | -43.2% | -48.4% | 36.4% | 60.0% | – | – | 99.9% | – | – |
| Free cash flow 1Y growth | -114.0% | – | – | – | – | – | – | – | – | – | – | – |
| Total assets 1Y growth | -13.7% | 151.8% | 178.7% | -74.9% | 688.4% | -22.2% | -78.0% | – | – | -89.8% | -41.2% | – |
| Total assets 3Y CAGR | 82.3% | 20.8% | 76.7% | 15.5% | 10.5% | – | – | 148.3% | – | – | – | – |
| Total assets 5Y CAGR | 64.3% | 61.0% | -1.1% | – | – | 21.3% | -19.3% | -1.8% | – | – | – | – |
| Total assets 10Y CAGR | 41.2% | 14.0% | -1.4% | – | – | – | – | – | – | – | – | – |
| Total equity 1Y growth | -45.5% | 11.1% | -13.4% | -32.8% | 20.7% | -64.2% | -21.1% | -19,692.9% | – | -173,723.9% | -100.1% | – |
Every figure here is calculated from standardized financial statements — hover a row name for the formula — not reported by the company. Valuation multiples use the closing price at the end of that period, not today's price.